MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,434,922 | $45,343,535 | 1.82% |
| Rock Springs Capital Management LP | 1,820,733 | $57,535,163 | 1.54% |
| Avidity Partners Management LP | 1,142,850 | $36,114,060 | 1.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 110,114 | $3,479,602 | 1.06% |
| Penn Capital Management Company, LLC | 245,970 | $7,782,862 | 0.80% |
| Values First Advisors, Inc. | 37,919 | $1,198,242 | 0.77% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,500 | $2,128,950 | 0.72% |
| Perceptive Advisors | 672,042 | $21,236,527 | 0.71% |
| ARDSLEY ADVISORY PARTNERS LP | 100,000 | $3,160,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 114,284 | $3,611,374 | 0.66% |
External links
This page lists MIRUM PHARMACEUTICALS INC's shareholders in Q3 2023. To view MIRUM PHARMACEUTICALS INC's shareholder history, click here.